Top Aesthetic Trends in 2020

The global aesthetics market (https://tinyurl.com/y6h9qn6pis) is booming and this has been reflected in the UK, largely driven by social media. Image and video-based platforms, like Instagram and Facebook, have given aesthetic brands ample opportunity to introduce new...

New additions to the Medira range

Tropocells® Medira is pleased to announce the inclusion of the Tropocells® PRP/TRS/PRF range of products.   Cellenis® brand will be used exclusively for Aesthetics, while the Tropocells® brand will be used for dental, oral maxillofacial, ENT and wound...
Cellenis Featured in ASDS Annual Meeting In Chicago

Cellenis Featured in ASDS Annual Meeting In Chicago

For the second year, Cellenis PRP has featured in a study presentation at the American Society for Dermatologic Surgery annual meeting in Chicago.   The seminar delivered by Matthew J. Lin, MD, a dermatologist at Icahn School of Medicine at Mount Sinai, focused...
EPO Revokes Regenlab PRP Patent

EPO Revokes Regenlab PRP Patent

Estar Medical has been successful in revoking Regenlab’s original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of...
Cellenis European Patent upheld in High Court

Cellenis European Patent upheld in High Court

Medira is very pleased to report that a challenge to its European patent on Cellenis filed by Regen Lab has been revoked as it was found that it ‘lacked novelty and an inventive step’. This follows a similar outcome that was delivered in the US and the...